Detecting viable myocardium and predicting functional improvement - Comparisons of positron emission tomography, rest-redistribution thallium-201 single-photon emission computed tomography (SPECT), exercise thallium-201 reinjection SPECT, I-123 BMIPP SPECT and dobutamine stress echocardiography

Circulation Journal

Volumn 68, Issue 10, 2004, Pages 950-957

  Tani, Tomoko ^a,b   Teragaki, Masakazu ^a   Watanabe, Hiroyuki ^a   Muro, Takashi ^a   Yamagishi, Hiroyuki ^a   Akioka, Kaname ^a   Yoshiyama, Minoru ^a   Takeuchi, Kazuhide ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

BMIPP; FDG PET; LDDE; Myocardial viability; Tl SPECT

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BICYCLE ERGOMETER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART VENTRICLE WALL MOTION; HUMAN; INTERMETHOD COMPARISON; MALE; MYOCARDIUM VIABILITY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; STUNNED HEART MUSCLE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; POSITRON-EMISSION TOMOGRAPHY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 6944227506     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.950     Document Type: Article

References (23)

1. Yamagishi H, Akioka K, Takagi M, Tanaka A, Takeuchi K, Yoshikawa J, et al. Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction. Heart 1998; 80: 28-34.
2. Perrone-Filardi P, Pace L, Prastaro M, Squame F, Betocchi S, Soricelli S, et al. Assessment of myocardial viability in patients with chronic coronary artery disease: Rest-4-hour-24 201Tl tomography versus dobutamine echocardiography. Circulation 1996; 94: 2712-2719.
3. 201Tl uptake and comparative prediction of recovery of function. Circulation 1997; 95: 626-635.
4. Elhendy A, Trocino G, Salustri A, Cornel JH, Roelandt JR, Boersma E, et al. Low-dose dobutamine echocardiography and rest-redistribution thallium-201 tomography in the assessment of spontaneous recovery of left ventricular function after recent myocardial infarction. Am Heart J 1996; 131: 1088-1096.
5. Smart S, Stoiber T, Hellman R, Duchak J, Wynsen J, Kitapci M, et al. Low dose dobutamine echocardiography is more predictive of reversible dysfunction after acute myocardial infarction than resting single-photon emission computed tomographic thallium-201 scintigraphy. Am Heart J 1997; 133: 822-834.
6. Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Reiji AE, et al. Prediction of recovery of myocardial dysfunction after revascularization: Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28: 558-564.
7. Haque T, Furukawa T, Takahashi M, Kinoshita M. Identification of hibernating myocardium by dobutamine stress echocardiography: Comparison with thallium-201 reinjection imaging. Am Heart J 1995; 130: G553-G563.
8. Pierard LA, Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021-1031.
9. Chan RK, Lee KJ, Calafiore P, Berlangieri SU, Mckey WJ, Tonkin AM. Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 1601-1607.
10. Mariani MA, Palagi C, Donatelli F, Mengozzi G, Biadi O, Vanoli G, et al. Identification of hibernating myocardium: A comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction. Am J Card Imaging 1995; 9: 1-8.
11. Baer FM, Voth E, Deutsch HJ, Schneider CA, Schicha H, Sechtem U. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 1994; 24: 43-53.
12. Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst H, de Vivie ER, et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996; 28: 60-69.
13. Nakano A, Kondo M, Tokunaga S, Akiyama K, Mori Y, Nosue Y, et al. Serial change of 1231-BM1PP SPECT imaging during recovery from stunned myocardium after acute myocardial infarction: Correlation with 201-Tl and two-dimensional echocardiography. Kaku Igaku 1995; 32: 227-233.
14. Hashimoto A, Nakata T, Nagao K, Kobayashi H, Hase M, Yoshioka N, et al. Prediction of left ventricular functional recovery in patients with acute myocardial infarction using single photon emission computed tomography with thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid. J Cardiol 1995; 26: 59-68.
15. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
16. Naruse H, Arii T, Kondo T, Morita M, Ohyanagi M, Iwasaki T, et al. Clinical usefulness of iodine 123-labeled fatty acid imaging in patients with acute myocardial infarction. J Nucl Cardiol 1998; 5: 275-284.
17. Taki J, Nakajima K, Matsunari I, Bunko H, Takata S, Kawasuji M, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38: 1503-1510.
18. Sun KT, Czernin J, Krivokapich J, Lau YK, Bottcher M, Maurer G, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996; 94: 3146-3154.
19. Watada H, Ito H, Oh H, Masuyama T, Aburaya M, Hori M, et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994; 24: 624-630.
20. Tani T, Teragaki M, Watanabe H, Muro T, Yamagishi H, Akioka K, et al. Prediction of functional recovery in patients with myocardial infarction after revascularization: Comparison of low-dose dobutamine stress echocardiography with fluorine-18 fluorodeoxyglucose positron emission tomography. Jpn Circ J 2001; 65: 177-181.
21. Yasugi N, Koyanagi S, Ohzono K, Sakai K, Matsumoto T, Sako S, et al. Comparative study of dobutamine stress echocardiography and dual single-photon emission computed tomography (thallium-201 and 1-123 BMIPP) for assessing myocardial viability after acute myocardial infarction. Circ J 2002; 66: 1132-1138.
22. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkoritz K, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88: 405-415.
23. Leclercq F, Messner-Pellenc P, Moragues C, Rivalland F, Carabasse D, Davy JM, et al. Myocardial viability assessed by dobutamine echocardiography in acute myocardial infarction after successful primary coronary angioplasty. Am J Cardiol 1997; 80: 6-10.